US Patent 9808359 Treatment systems processes and devices addressing cerebral vasospasm/vasoconstriction
Patent 9808359 was granted and assigned to Neurvana Medical, Llc on November, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 13, 2016
Date of Patent
November 7, 2017
Patent Application Number
15154927
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9808359 Treatment systems processes and devices addressing cerebral vasospasm/vasoconstriction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.